The information on this page is intended for journalists, press and media. Click YES to get to the newsroom. If you click NO you will come back to Mynewsdesk.com.
NNIT’s Migration Powerhouse, renowned for its expertise in critical data migrations where compliance and accuracy are paramount, is proud to announce the launch of the latest iteration of its flagship software, Valiance TRUseries 5.0.
Our China head office has relocated from Tianjin Jinwan Mansion to Tianjin Luneng International Center to provide employees with a more convenient and flexible office environment as well as better surroundings for the collaboration with our customers and partners.
More than 400 talented and ambitious young people were nominated for this year's Talent 100 published by Berlingske. Only 100 talents were ultimately selected for this year’s list, and Marina Prodan is one of them.
NNIT completes successful collaboration with a Top 20 Biopharma pioneer in transitioning to a new Electronic Data Capture (EDC) platform for their clinical trials.
Nearly half of the respondents in NNIT’s Expectation Barometer 2023 survey place heightened integration of AI at the top of their priority list. However, prior to fully embracing AI, life sciences companies should prioritize the people and business processes that will become AI’s closest allies.
The Group improved business and financial performance throughout the year and delivered on the outlook, which was upgraded in August, 2023.
Like the rest of the world, the life sciences industry is right in the eye of a raging storm of multiple rapid changes. According to Ricco Larsen, Senior Vice President at NNIT, the top priority for pharma companies is to invest in a solid data foundation so they are fully prepared for what comes next.
The potential benefits of an electronic Trial Master File (eTMF) system extend far beyond clinical operations. As Tróndur Ellingsgaard, Advisory Consultant at NNIT explains, a mature eTMF can enhance efficiency, foster greater collaboration across the organization, and enable informed decision-making.
Everest Group has just released its Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024 (part of the Life Sciences Information Technology research program), and we are proud to announce that NNIT features among the Leaders.
Life science organizations face complex regulatory challenges, intensive audits, and robust internal process controls. With this new partnership, NNIT and Gimmal provide a well-established, compliant solution that customers operating within life sciences can rely on to manage the information lifecycle of GxP records.
As NNIT expands its presence in the United States, particularly with the anticipated integration of Excellis Health Solutions (Excellis), Greg Cathcart, Head of Excellis, will assume the lead role of Senior Vice President to accelerate growth and advance the market position in the US.
Implementing an electronic Trial Master File (eTMF) system can revolutionize the way clinical trials are managed. However, as Michael Agard, Director of Clinical Consulting at NNIT, points out, the true value of eTMF lies in post-implementation management.
We are proud to share that NNIT has once again received the highest Veeva partner acknowledgement and certification as Premiere Services Partner – Development Cloud.
Each year, Danish Tech publication Version2 calls for nominations of IT talents. The competition is subject to comprehensive nominations, screening and the scrutiny of a professional jury.
The backbone of every clinical trial is undergoing an inevitable digital revolution. Klaudia Markowski, Senior Business Consultant at NNIT, explains why the appropriate time to implement an electronic Trial Master File (eTMF) might be sooner than you think.
When talking about counterfeiting, most of us think about major consumer brands but, unfortunately, counterfeiting is also a major and growing problem within the life sciences industry – and to make matters worse, nobody knows exactly how big the problem is.
Brooke Casselberry recognized as one of industry’s most inspiring
When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.
To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.
Please note that our Terms of Use apply to all use of our services.
You can withdraw your consent at any time by unsubscribing or deleting your account.
Email sent to __email__. Click the link there to follow NNIT News.
